Is Magnesium Taurate Cognition Randomized Trial safe?

The current Migaku evidence database contains 1 reusable source document for Magnesium Taurate Cognition Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Based on the NSTEA questionnaire, 73% of participants rated the Overall Benefit as Moderate, Good, or Great, with scores that were substantially higher than the NSTEA study found for multi-vitamins, the average of 58 nutraceuticals, and the average of 28 psychiatric and seizure medications. [Adams JB (2022); evidence level 4] - Sub-analysis found that the Overall Benefit of ANRC-EP was not significantly affected by gender, age, autism severity, diet quality, self-limited diet, use of psychiatric or seizure medications, dosage, developmental history, intellectual disability, or seizures. [Adams JB (2022); evidence level 4] - Conclusions This study found that ANRC-EP had significant benefits for a wide range of symptoms, and low adverse effects. [Adams JB (2022); evidence level 4] - Background Vitamin and mineral supplements are widely used by children and adults diagnosed with autism spectrum disorder (ASD). [Adams JB (2022); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.